Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;14(4):209-220.
doi: 10.18502/jfrh.v14i4.5204.

Controversial Screening for Thyroid Dysfunction in Preconception and Pregnancy: An Evidence-Based Review

Joana Lima Ferreira  1 , Mafalda Gomes  2 , Rosa Maria Príncipe  1
Affiliations
Review

Controversial Screening for Thyroid Dysfunction in Preconception and Pregnancy: An Evidence-Based Review

Joana Lima Ferreira et al. J Family Reprod Health. 2020 Dec.

Abstract

Objective: To evaluate the recommendations on the most adequate screening method (universal or selective) for thyroid dysfunction. Although thyroid dysfunction is a common disorder in fertile women and untreated cases may have negative maternal, fetal and neonatal outcomes, its screening in preconception and early pregnancy is controversial. Materials and methods: An evidence-based review was conducted to identify publications since 2017 of American Thyroid Association (ATA) guidelines, according to the following Population, Intervention, Comparison, Outcomes and Study (PICOS): women in preconception or pregnancy without thyroid disease who underwent universal or selective screening for thyroid dysfunction. Study selection obeyed the PRISMA criteria. Results: We included 15 of 325 publications. The 2017 ATA guidelines recommend selective screening in both preconception and pregnancy. The only two reviews on preconception recommended universal screening. For pregnancy, nine articles suggested universal screening, while a prospective study advocated selective screening. The main benefits advocated for universal screening were easy and low-cost tests; absence of missed diagnosis; safe and inexpensive treatment and its potential in preventing negative outcomes. Iodine deficiency is a decisive indication, but it was not evaluated in all clinical studies. Screening harms and knowledge gaps were the main arguments against universal screening. There are very few cost-effectiveness studies. Conclusion: We recommend universal screening for thyroid dysfunction in early pregnancy, which is a distinct point of view from 2017 ATA guidelines (weak recommendation, low-quality evidence). It is not possible to make a formal recommendation for preconception (insufficient evidence). We strongly suggest an individualized analysis by each country.

Keywords: Endocrinology; Maternal Health; Preconception; Pregnancy; Primary Health Care; Screening; Thyroid Function.

PubMed Disclaimer

References

    1. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:2543–65. - PubMed
    1. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27:315–89. - PubMed
    1. Martinez M, Soldevila B, Lucas A, Velasco I, Vila L, Puig-Domingo M. Hypothyroidism during pregnancy and its association to perinatal and obstetric morbidity: a review. Endocrinol Diabetes Nutr. 2018;65:107–13. - PubMed
    1. Stagnaro-Green A. Clinical guidelines: Thyroid and pregnancy-time for universal screening? Nat Rev Endocrinol. 2017;13:192–4. - PubMed
    1. Koehler VF, Auernhammer CJ, Spitzweg C. [The Thyroid and Pregnancy] Dtsch Med Wochenschr. 2019;144:1681–5. - PubMed

LinkOut - more resources